Your browser doesn't support javascript.
loading
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Shah, Manisha H; Goldner, Whitney S; Benson, Al B; Bergsland, Emily; Blaszkowsky, Lawrence S; Brock, Pamela; Chan, Jennifer; Das, Satya; Dickson, Paxton V; Fanta, Paul; Giordano, Thomas; Halfdanarson, Thorvardur R; Halperin, Daniel; He, Jin; Heaney, Anthony; Heslin, Martin J; Kandeel, Fouad; Kardan, Arash; Khan, Sajid A; Kuvshinoff, Boris W; Lieu, Christopher; Miller, Kimberly; Pillarisetty, Venu G; Reidy, Diane; Salgado, Sarimar Agosto; Shaheen, Shagufta; Soares, Heloisa P; Soulen, Michael C; Strosberg, Jonathan R; Sussman, Craig R; Trikalinos, Nikolaos A; Uboha, Nataliya A; Vijayvergia, Namrata; Wong, Terence; Lynn, Beth; Hochstetler, Cindy.
Afiliación
  • Shah MH; 1The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Goldner WS; 2Fred & Pamela Buffett Cancer Center.
  • Benson AB; 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Bergsland E; 4UCSF Helen Diller Family Comprehensive Cancer Center.
  • Blaszkowsky LS; 5Massachusetts General Hospital Cancer Center.
  • Brock P; 1The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Chan J; 6Dana-Farber/Brigham and Women's Cancer Center.
  • Das S; 7Vanderbilt-Ingram Cancer Center.
  • Dickson PV; 8St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
  • Fanta P; 9UC San Diego Moores Cancer Center.
  • Giordano T; 10University of Michigan Rogel Cancer Center.
  • Halfdanarson TR; 11Mayo Clinic Cancer Center.
  • Halperin D; 12The University of Texas MD Anderson Cancer Center.
  • He J; 13The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Heaney A; 14UCLA Jonsson Comprehensive Cancer Center.
  • Heslin MJ; 15O'Neal Comprehensive Cancer Center at UAB.
  • Kandeel F; 16City of Hope National Medical Center.
  • Kardan A; 17Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Khan SA; 18Yale Cancer Center/Smilow Cancer Hospital.
  • Kuvshinoff BW; 19Roswell Park Comprehensive Cancer Center.
  • Lieu C; 20University of Colorado Cancer Center.
  • Miller K; 2Fred & Pamela Buffett Cancer Center.
  • Pillarisetty VG; 21Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Reidy D; 22Memorial Sloan Kettering Cancer Center.
  • Salgado SA; 23UT Southwestern Simmons Comprehensive Cancer Center.
  • Shaheen S; 24Stanford Cancer Institute.
  • Soares HP; 25Huntsman Cancer Institute at the University of Utah.
  • Soulen MC; 26Abramson Cancer Center at the University of Pennsylvania.
  • Strosberg JR; 27Moffitt Cancer Center.
  • Sussman CR; 7Vanderbilt-Ingram Cancer Center.
  • Trikalinos NA; 28Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Uboha NA; 29University of Wisconsin Carbone Cancer Center.
  • Vijayvergia N; 30Fox Chase Cancer Center.
  • Wong T; 31Duke Cancer Institute; and.
  • Lynn B; 32National Comprehensive Cancer Network.
  • Hochstetler C; 32National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 19(7): 839-868, 2021 07 28.
Article en En | MEDLINE | ID: mdl-34340212
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paragangliomas, and multiple endocrine neoplasia. NETs are generally subclassified by site of origin, stage, and histologic characteristics. Appropriate diagnosis and treatment of NETs often involves collaboration between specialists in multiple disciplines, using specific biochemical, radiologic, and surgical methods. Specialists include pathologists, endocrinologists, radiologists (including nuclear medicine specialists), and medical, radiation, and surgical oncologists. These guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine and adrenal tumors and are intended to assist with clinical decision-making. This article is focused on the 2021 NCCN Guidelines principles of genetic risk assessment and counseling and recommendations for well-differentiated grade 3 NETs, poorly differentiated neuroendocrine carcinomas, adrenal tumors, pheochromocytomas, and paragangliomas.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tumores Neuroendocrinos / Neoplasias de las Glándulas Suprarrenales Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tumores Neuroendocrinos / Neoplasias de las Glándulas Suprarrenales Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos